Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
CELL.MI Stock Summary
In the News
CELL.MI Financial details
Company Rating
Buy
Market Cap
60.38M
Income
4.87M
Revenue
233.11M
Book val./share
6.37
Cash/share
0.66
Dividend
-
Dividend %
-
Employees
299
Optionable
No
Shortable
Yes
Earnings
08 May 2024
P/E
0
Forward P/E
-
PEG
-
P/S
0.4
P/B
-
P/C
4.21
P/FCF
22.49
Quick Ratio
0.19
Current Ratio
1.79
Debt / Equity
0.28
LT Debt / Equity
0.06
-
-
EPS (TTM)
0.23
EPS next Y
-
EPS next Q
-
EPS this Y
-104.83%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-27.35%
Revenue last 5Y
2.47%
Revenue Q/Q
105.28%
EPS Q/Q
111.76%
-
-
-
-
SMA20
-1.41%
SMA50
9.84%
SMA100
20.26%
Inst Own
-
Inst Trans
-
ROA
-12%
ROE
-22%
ROC
-0.17%
Gross Margin
40%
Oper. Margin
-21%
Profit Margin
-22%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
2.07-3.07
52W High
-7.33%
52W Low
+39%
RSI
48.07
Rel Volume
0.04
Avg Volume
40.32K
Volume
1.69K
Perf Week
-0.71%
Perf Month
-3.47%
Perf Quarter
23.01%
Perf Half Y
19.83%
-
-
-
-
Beta
0.711
-
-
Volatility
0.01%, 0.04%
Prev Close
0%
Price
2.78
Change
-0.36%
CELL.MI Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 6.5 | 4.84 | 5.12 | 6.45 | 7.5 | |
Net income per share | 0.84 | 0.64 | -0.18 | -3.52 | 0.17 | |
Operating cash flow per share | 0.94 | 0.52 | 0.88 | 0.23 | 0.62 | |
Free cash flow per share | 0.56 | 0.05 | 0.65 | 0.01 | 0.39 | |
Cash per share | 1.49 | 0.4 | 0.38 | 0.47 | 0.66 | |
Book value per share | 9.38 | 9.65 | 9.5 | 6.11 | 6.37 | |
Tangible book value per share | 1.48 | 1.26 | 1.63 | 1.94 | 4.55 | |
Share holders equity per share | 9.38 | 9.65 | 9.5 | 6.11 | 6.37 | |
Interest debt per share | 2.52 | 2.22 | 1.71 | 1.91 | 1.97 | |
Market cap | 141.46M | 99.57M | 86.87M | 61.26M | 49.48M | |
Enterprise value | 162.21M | 137.14M | 114.5M | 90.84M | 73.21M | |
P/E ratio | 7.77 | 7.16 | -22.59 | -0.81 | 13.76 | |
Price to sales ratio | 1.01 | 0.95 | 0.79 | 0.45 | 0.31 | |
POCF ratio | 6.95 | 8.81 | 4.55 | 12.53 | 3.79 | |
PFCF ratio | 11.73 | 87.65 | 6.17 | 218.78 | 6.07 | |
P/B Ratio | 0.7 | 0.48 | 0.42 | 0.47 | 0.37 | |
PTB ratio | 0.7 | 0.48 | 0.42 | 0.47 | 0.37 | |
EV to sales | 1.16 | 1.31 | 1.04 | 0.66 | 0.46 | |
Enterprise value over EBITDA | 5.37 | 8.64 | 5.51 | 6.27 | 4.17 | |
EV to operating cash flow | 7.96 | 12.13 | 6 | 18.58 | 5.61 | |
EV to free cash flow | 13.46 | 120.72 | 8.14 | 324.42 | 8.98 | |
Earnings yield | 0.13 | 0.14 | -0.04 | -1.23 | 0.07 | |
Free cash flow yield | 0.09 | 0.01 | 0.16 | 0 | 0.16 | |
Debt to equity | 0.26 | 0.22 | 0.17 | 0.3 | 0.28 | |
Debt to assets | 0.17 | 0.16 | 0.13 | 0.18 | 0.16 | |
Net debt to EBITDA | 0.69 | 2.37 | 1.33 | 2.04 | 1.35 | |
Current ratio | 3.12 | 2.54 | 2.56 | 1.98 | 1.68 | |
Interest coverage | 12.05 | 0.56 | 1.53 | -60.17 | 1.05 | |
Income quality | 1.12 | 0.81 | -4.96 | -0.07 | 3.63 | |
Dividend Yield | 0.04 | 0.07 | 0 | 0.02 | 0 | |
Payout ratio | 0.33 | 0.48 | 0 | -0.01 | 0 | |
Sales general and administrative to revenue | 0.04 | 0.05 | 0.05 | 0.05 | 0 | |
Research and developement to revenue | 0.02 | 0 | 0 | 0.01 | 0 | |
Intangibles to total assets | 0.56 | 0.62 | 0.61 | 0.41 | 0.16 | |
Capex to operating cash flow | -0.41 | -0.9 | -0.26 | -0.94 | -0.38 | |
Capex to revenue | -0.06 | -0.1 | -0.05 | -0.03 | -0.03 | |
Capex to depreciation | -0.86 | -0.68 | -0.26 | -0.05 | -0.37 | |
Stock based compensation to revenue | 0.01 | 0.16 | 0.03 | 0 | 0 | |
Graham number | 13.34 | 11.82 | 6.17 | 22.01 | 4.94 | |
ROIC | 0.07 | -0.02 | 0 | -0.44 | 0.02 | |
Return on tangible assets | 0.13 | 0.12 | -0.03 | -0.59 | 0.02 | |
Graham Net | -0.39 | -0.92 | -0.58 | -0.62 | -1.05 | |
Working capital | 85.16M | 61.06M | 59.04M | 53.87M | 51.25M | |
Tangible asset value | 31.9M | 27.11M | 35.23M | 41.37M | 96.15M | |
Net current asset value | 20.73M | 15.1M | 21.16M | 24.06M | 27.56M | |
Invested capital | 0.26 | 0.22 | 0.17 | 0.3 | 0.28 | |
Average receivables | 65.34M | 63.02M | 54.54M | 55.09M | 53.9M | |
Average payables | 19.62M | 17.27M | 17.66M | 21.7M | 27.96M | |
Average inventory | 20.56M | 26.66M | 30.35M | 34.28M | 43.36M | |
Days sales outstanding | 185.21 | 191.22 | 179.27 | 148.15 | 119.48 | |
Days payables outstanding | 91.73 | 94.81 | 116.03 | 102.2 | 121.08 | |
Days of inventory on hand | 102.98 | 195.53 | 168.36 | 172.47 | 175.76 | |
Receivables turnover | 1.97 | 1.91 | 2.04 | 2.46 | 3.05 | |
Payables turnover | 3.98 | 3.85 | 3.15 | 3.57 | 3.01 | |
Inventory turnover | 3.54 | 1.87 | 2.17 | 2.12 | 2.08 | |
ROE | 0.09 | 0.07 | -0.02 | -0.58 | 0.03 | |
Capex per share | -0.38 | -0.47 | -0.23 | -0.22 | -0.23 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 1.96 | 1.43 | 3.22 | 2.09 | 4.3 | |
Net income per share | -1.63 | -0.11 | -0.19 | 0.18 | 0.36 | |
Operating cash flow per share | 0.28 | -0.22 | 0.05 | 0.18 | 0.56 | |
Free cash flow per share | 0.2 | -0.25 | -0.05 | 0.13 | 0.44 | |
Cash per share | 0.46 | 0.49 | 0.59 | 0.52 | 0.66 | |
Book value per share | 6.05 | 6.04 | 6 | 6.15 | 6.37 | |
Tangible book value per share | 1.92 | 1.76 | 1.64 | 1.89 | 4.55 | |
Share holders equity per share | 6.05 | 6.04 | 6 | 6.15 | 6.37 | |
Interest debt per share | 1.82 | 1.61 | 2.29 | 1.4 | 1.89 | |
Market cap | 61.92M | 63.23M | 58.05M | 48.43M | 49.48M | |
Enterprise value | 91.5M | 52.89M | 92.08M | 37.5M | 73.21M | |
P/E ratio | -0.44 | -6.51 | -3.6 | 3.27 | 1.62 | |
Price to sales ratio | 1.46 | 2.09 | 0.86 | 1.09 | 0.54 | |
POCF ratio | 10.41 | -13.57 | 50.79 | 13.04 | 4.16 | |
PFCF ratio | 14.57 | -11.97 | -53.26 | 17.65 | 5.35 | |
P/B Ratio | 0.47 | 0.49 | 0.46 | 0.37 | 0.37 | |
PTB ratio | 0.47 | 0.49 | 0.46 | 0.37 | 0.37 | |
EV to sales | 2.16 | 1.75 | 1.36 | 0.85 | 0.81 | |
Enterprise value over EBITDA | 23.86 | -209.07 | 29.72 | 4.4 | 16.15 | |
EV to operating cash flow | 15.39 | -11.36 | 80.56 | 10.09 | 6.15 | |
EV to free cash flow | 21.53 | -10.01 | -84.48 | 13.67 | 7.92 | |
Earnings yield | -0.57 | -0.04 | -0.07 | 0.08 | 0.15 | |
Free cash flow yield | 0.07 | -0.08 | -0.02 | 0.06 | 0.19 | |
Debt to equity | 0.3 | 0.27 | 0.37 | 0.22 | 0.28 | |
Debt to assets | 0.18 | 0.15 | 0.2 | 0.12 | 0.16 | |
Net debt to EBITDA | 7.72 | 40.85 | 10.98 | -1.28 | 5.23 | |
Current ratio | 1.98 | 1.95 | 1.79 | 1.86 | 1.68 | |
Interest coverage | 106.85 | 0 | -1.85 | 3.25 | -1.14 | |
Income quality | -0.17 | 1.92 | -0.28 | 1 | 1.56 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | -1.24 | 0.22 | 0.1 | 0.39 | 0 | |
Research and developement to revenue | 0.03 | 0 | 0.01 | 0.01 | 0 | |
Intangibles to total assets | 0.41 | 0.4 | 0.4 | 0.39 | 0.16 | |
Capex to operating cash flow | -0.29 | 0.13 | -1.95 | -0.26 | -0.22 | |
Capex to revenue | -0.04 | -0.02 | -0.03 | -0.02 | -0.03 | |
Capex to depreciation | -0.04 | -0.21 | -0.35 | -0.28 | -0.38 | |
Stock based compensation to revenue | -0.03 | 0 | -0.15 | 0 | 0 | |
Graham number | 14.88 | 3.95 | 5.09 | 4.92 | 7.19 | |
ROIC | -0.21 | -0.03 | -0.02 | 0.03 | -0.01 | |
Return on tangible assets | -0.28 | -0.02 | -0.03 | 0.03 | 0.04 | |
Graham Net | -0.61 | -1.36 | -1.34 | -0.98 | -1.05 | |
Working capital | 53.87M | 58.56M | 52.33M | 56.69M | 51.25M | |
Tangible asset value | 41.37M | 37.21M | 34.57M | 40M | 96.15M | |
Net current asset value | 24.06M | 18.94M | 16.83M | 22.24M | 27.56M | |
Invested capital | 0.3 | 0.27 | 0.37 | 0.22 | 0.28 | |
Average receivables | 55.78M | 53.43M | 49.99M | 53.18M | 54.66M | |
Average payables | 25.12M | 26.61M | 28.31M | 28.4M | 31.06M | |
Average inventory | 43.21M | 43.58M | 48.27M | 50.4M | 49.27M | |
Days sales outstanding | 118.81 | 151.9 | 65 | 116.72 | 51.46 | |
Days payables outstanding | 88.52 | 134.35 | 48.66 | 105.92 | 47.75 | |
Days of inventory on hand | 149.39 | 214.73 | 88.65 | 183.44 | 69.32 | |
Receivables turnover | 0.76 | 0.59 | 1.38 | 0.77 | 1.75 | |
Payables turnover | 1.02 | 0.67 | 1.85 | 0.85 | 1.88 | |
Inventory turnover | 0.6 | 0.42 | 1.02 | 0.49 | 1.3 | |
ROE | -0.27 | -0.02 | -0.03 | 0.03 | 0.06 | |
Capex per share | -0.08 | -0.03 | -0.11 | -0.05 | -0.13 |
CELL.MI Frequently Asked Questions
What is Cellularline S.p.A. stock symbol ?
Cellularline S.p.A. is a IT stock , located in Reggio emilia of Re and trading under the symbol CELL.MI
What is Cellularline S.p.A. stock quote today ?
Cellularline S.p.A. stock price is $2.78 today.
Is Cellularline S.p.A. stock public?
Yes, Cellularline S.p.A. is a publicly traded company.